View in EDS

CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.

Saved in:
Bibliographic Details
Title: CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.
Authors: Lopez CD; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Kardosh A; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Chen EY; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Pegna G; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Guimaraes A; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Radiology, OHSU, OR 97239, Portland., Foster B; Department of Pathology, OHSU, OR 97239, Portland., Brinkerhoff B; Department of Pathology, OHSU, OR 97239, Portland., Goodyear SM; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Lim JY; Biostatistics Shared Resource, Knight Cancer Institute (OHSU)., Taber E; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Rajagopalan B; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Edmerson E; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Vo J; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Nelson K; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Jackson A; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Gingerich T; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Fahlman A; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Lessenich C; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Fennell F; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Ventura D; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Roy P; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland., Keith D; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland., Sheppard B; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Surgery, OHSU, OR 97239, Portland., Brody JR; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Surgery, OHSU, OR 97239, Portland., Mills GB; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Precision Oncology, Knight Cancer Institute OHSU, OR 97239, Portland., Ronai ZA; Sanford Burnham Prebys, La Jolla, CA 92037, San Diego., Sears RC; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Molecular and Medical Genetics, OHSU, OR 97239, Portland.
Source: Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (37), pp. 2915-2925. Date of Electronic Publication: 2024 Oct 08.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39378065
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lopez+CD%22">Lopez CD</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.<br /><searchLink fieldCode="AU" term="%22Kardosh+A%22">Kardosh A</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.<br /><searchLink fieldCode="AU" term="%22Chen+EY%22">Chen EY</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Pegna+G%22">Pegna G</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Guimaraes+A%22">Guimaraes A</searchLink>; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Radiology, OHSU, OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Foster+B%22">Foster B</searchLink>; Department of Pathology, OHSU, OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Brinkerhoff+B%22">Brinkerhoff B</searchLink>; Department of Pathology, OHSU, OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Goodyear+SM%22">Goodyear SM</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.<br /><searchLink fieldCode="AU" term="%22Lim+JY%22">Lim JY</searchLink>; Biostatistics Shared Resource, Knight Cancer Institute (OHSU).<br /><searchLink fieldCode="AU" term="%22Taber+E%22">Taber E</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Rajagopalan+B%22">Rajagopalan B</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Edmerson+E%22">Edmerson E</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Vo+J%22">Vo J</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Nelson+K%22">Nelson K</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Jackson+A%22">Jackson A</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Gingerich+T%22">Gingerich T</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Fahlman+A%22">Fahlman A</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Lessenich+C%22">Lessenich C</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Fennell+F%22">Fennell F</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Ventura+D%22">Ventura D</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Roy+P%22">Roy P</searchLink>; Department of Medicine, Hematology and Medical Oncology, Oregon Health & Science University (OHSU), OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Keith+D%22">Keith D</searchLink>; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.<br /><searchLink fieldCode="AU" term="%22Sheppard+B%22">Sheppard B</searchLink>; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Surgery, OHSU, OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Brody+JR%22">Brody JR</searchLink>; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Surgery, OHSU, OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Mills+GB%22">Mills GB</searchLink>; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Precision Oncology, Knight Cancer Institute OHSU, OR 97239, Portland.<br /><searchLink fieldCode="AU" term="%22Ronai+ZA%22">Ronai ZA</searchLink>; Sanford Burnham Prebys, La Jolla, CA 92037, San Diego.<br /><searchLink fieldCode="AU" term="%22Sears+RC%22">Sears RC</searchLink>; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute (OHSU), OR, Portland.; Department of Molecular and Medical Genetics, OHSU, OR 97239, Portland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2024; Vol. 20 (37), pp. 2915-2925. <i>Date of Electronic Publication: </i>2024 Oct 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39378065
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2024.2395235
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2915
    Titles:
      – TitleFull: CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lopez CD
      – PersonEntity:
          Name:
            NameFull: Kardosh A
      – PersonEntity:
          Name:
            NameFull: Chen EY
      – PersonEntity:
          Name:
            NameFull: Pegna G
      – PersonEntity:
          Name:
            NameFull: Guimaraes A
      – PersonEntity:
          Name:
            NameFull: Foster B
      – PersonEntity:
          Name:
            NameFull: Brinkerhoff B
      – PersonEntity:
          Name:
            NameFull: Goodyear SM
      – PersonEntity:
          Name:
            NameFull: Lim JY
      – PersonEntity:
          Name:
            NameFull: Taber E
      – PersonEntity:
          Name:
            NameFull: Rajagopalan B
      – PersonEntity:
          Name:
            NameFull: Edmerson E
      – PersonEntity:
          Name:
            NameFull: Vo J
      – PersonEntity:
          Name:
            NameFull: Nelson K
      – PersonEntity:
          Name:
            NameFull: Jackson A
      – PersonEntity:
          Name:
            NameFull: Gingerich T
      – PersonEntity:
          Name:
            NameFull: Fahlman A
      – PersonEntity:
          Name:
            NameFull: Lessenich C
      – PersonEntity:
          Name:
            NameFull: Fennell F
      – PersonEntity:
          Name:
            NameFull: Ventura D
      – PersonEntity:
          Name:
            NameFull: Roy P
      – PersonEntity:
          Name:
            NameFull: Keith D
      – PersonEntity:
          Name:
            NameFull: Sheppard B
      – PersonEntity:
          Name:
            NameFull: Brody JR
      – PersonEntity:
          Name:
            NameFull: Mills GB
      – PersonEntity:
          Name:
            NameFull: Ronai ZA
      – PersonEntity:
          Name:
            NameFull: Sears RC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 37
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1